Tumor circadian clock strength influences metastatic potential and predicts patient prognosis in luminal A breast cancer.

MLA

Shi-Yang Li, et al. “Tumor Circadian Clock Strength Influences Metastatic Potential and Predicts Patient Prognosis in Luminal A Breast Cancer.” Proceedings of the National Academy of Sciences of the United States of America, vol. 121, no. 7, Feb. 2024, pp. 1–12. EBSCOhost, https://doi.org/10.1073/pnas.2311854121.

APA

Shi-Yang Li, Hammarlund, J. A., Gang Wu, Jia-Wen Lian, Howell, S. J., Clarke, R. B., Adamson, A. D., Gonçalves, C. F., Hogenesch, J. B., Anafi, R. C., & Qing-Jun Meng. (2024). Tumor circadian clock strength influences metastatic potential and predicts patient prognosis in luminal A breast cancer. Proceedings of the National Academy of Sciences of the United States of America, 121(7), 1–12. https://doi.org/10.1073/pnas.2311854121

Chicago

Shi-Yang Li, Jan A. Hammarlund, Gang Wu, Jia-Wen Lian, Sacha J. Howell, Robert B. Clarke, Antony D. Adamson, et al. 2024. “Tumor Circadian Clock Strength Influences Metastatic Potential and Predicts Patient Prognosis in Luminal A Breast Cancer.” Proceedings of the National Academy of Sciences of the United States of America 121 (7): 1–12. doi:10.1073/pnas.2311854121.